The 20 Best Hereditary Ataxia Doctors Near Me in Ann Arbor, MI

Sharan Srinivasan is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Srinivasan is rated as a Distinguished provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 108 other conditions, according to our data. His clinical expertise encompasses Hereditary Ataxia, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 4, and Spinocerebellar Ataxia Type 5. Dr. Srinivasan is board certified in Neurology.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as a Distinguished provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology.

Kenneth Tobin is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Tobin is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, and Bicuspid Aortic Valve. Dr. Tobin is board certified in Cardiology.

Dr. Dorfman was born and raised in southeast Michigan, and returned home in 2007 after training and working as faculty at Children’s Hospital Boston and Harvard Medical School. He is co-director of congenital and pediatric cardiovascular magnetic resonance imaging and attends in the echocardiography laboratory, as well as seeing patients in a general pediatric cardiology clinic. Dr. Dorfman is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Tetralogy of Fallot, Double Discordia, Transposition of the Great Arteries, and Hypoplastic Left Heart Syndrome (HLHS). Dr. Dorfman is board certified in Pediatric Cardiology.

Dr. Benjamin Singer is an Assistant Professor in Pulmonary and Critical Care Medicine in the Department of Internal Medicine at the University of Michigan. He received his undergraduate degree in mathematics at the University of Michigan in 2002. Dr. Singer completed his medical training and PhD in Neuroscience through the Medical Scientist Training Program, and subsequently completed residency in Internal Medicine and fellowship training in Pulmonary and Critical Care Medicine, all at the University of Michigan.Approximately half of patients who survive an episode of critical illness experience long term brain dysfunction, in the form of anxiety, depression, post traumatic stress, or cognitive impairment. Dr. Singer’s research focuses on basic and translational studies of long-term brain injury after critical illness, with a focus on sepsis. These studies utilize animal models of sepsis and patient autopsy specimens to examine the immune and vascular responses to sepsis in the brain that persist for weeks to months after the outward signs of illness have resolved. In collaboration with Dr. Bob Dickson, he also examines the role of the gut microbiome in initiation of brain injury and multiorgan failure during sepsis. The goal of this work is to identify strategies to minimize and rehabilitate ongoing brain injury in sepsis survivors. Areas of special clinical focus include the care of patients with advance neuromuscular disease requiring chronic assisted ventilation. Dr. Singer is supported by a National Institute of Neurological Disorders and Stroke Career Development Award, MICHR, and University of Michigan Depression Center. Dr. Singer is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Acute Interstitial Pneumonia, Obesity Hypoventilation Syndrome (OHS), and Interstitial Lung Disease. Dr. Singer is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Diana Gomez is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Gomez is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Sciatica, Relapsing Multiple Sclerosis (RMS), Cerebellar Degeneration, and Meningioma. Dr. Gomez is board certified in Diagnostic Radiology and Neuroradiology.

Sara Mirza is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Mirza is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cerebral Hypoxia, Lung Metastases, Acute Respiratory Distress Syndrome (ARDS), Gastrostomy, and Bone Marrow Aspiration.

Punithavathy Vijayakumar is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Vijayakumar is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Obstructive Sleep Apnea, Transient Ischemic Attack (TIA), and Migraine. Dr. Vijayakumar is board certified in Clinical Neurophysiology, Neurology, Neuromuscular Medicine, Sleep Medicine, and Vascular Neurology.

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as a Distinguished provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Philip Choi is an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Obesity Hypoventilation Syndrome (OHS), Secondary Immunodeficiency (SID), and Lung Metastases.

John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001. Dr. Fink is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome. Dr. Fink is board certified in Clinical Genetics and Neurology.

David Bloom is a Radiologist and a Pediatric Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Bloom is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, PIK3CA-Related Overgrowth Spectrum, Atresia of Small Intestine, and Parkes Weber Syndrome. Dr. Bloom is board certified in Diagnostic Radiology and Pediatric Radiology.

Giulia Ippolito, MD, MS, is a Urologist with fellowship training Female Pelvic Medicine and Reconstructive Surgery (FPMRS) and a Health Services Researcher at the University of Michigan. She completed her undergraduate degree at the University of Texas at Dallas (B.S, 2009) and Medical School at Texas A&M University (M.D., 2013). She completed General Surgery internship (2014) and Urology residency training at the University of Minnesota (2018), and subsequent fellowship in Urogynecology and Reconstructive Pelvic Surgery (URPS, formerly Female Pelvic Medicine and Reconstructive Surgery) at the University of Michigan (2021). She also completed a master’s degree in Health and Healthcare Research at the University of Michigan in 2020. Dr. Ippolito joined the University of Michigan, Department of Urology, Division of Neurourology, and Pelvic Reconstruction in July 2021. Her clinical practice is at University Hospital, West Ann Arbor Clinic, St. Joseph Mercy Chelsea Hospital, and Lieutenant Colonel Charles S. Kettles VA Medical Center in Ann Arbor. Dr. Ippolito's clinical focus and practice includes evaluating and treating urinary incontinence, neurogenic bladder, female pelvic floor dysfunction (pelvic organ prolapse, urethral diverticuli, fistula), and reconstruction of the lower urinary tract including ureteral obstruction. She performs transvaginal and transabdominal repair of pelvic organ prolapse, female incontinence surgery such as urethral bulking, synthetic and autologous urethral slings, complex reconstruction including urinary diversions, augmentation, and ureteral reconstruction using open and robotic approaches. Dr. Ippolito is a NIDDK-funded K-12 Scholar under the University of Michigan UroEPI Career Development Program, and her research is focused on understanding and improving decision-making between patients and clinicians, especially in the care of overactive bladder. She is a member of several research collaboratives with the University of Michigan and across the nation (Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Research Network; Symptoms of Lower Urinary Tract Dysfunction Research Network). Dr. Ippolito is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bladder, Urinary Incontinence, Interstitial Cystitis, and Stress Urinary Incontinence.

Dr. Hornyak is Medical Director of Outpatient Pediatric Rehabilitation Services. He serves on the Evidence Based Practice Committee, and chairs the Evidence Committee, for the AAPM&R. He is actively involved in medical education, serving on the steering committee of the UM Academy of Medical Educators. His teaching has been recognized with departmental (Silver Crutch x 4), medical school (inaugural League of Educational Excellence) and university (Provost’s Teaching Innovation Prize) awards. Dr. Hornyak taught the medical portion of the Team-Based Clinical Decision Making course, the first course offered at UM for Inter-professional Education. He frequently serves on graduate student committees in the UM School of Kinesiology as well. Clinically, Dr. Hornyak practices pediatric and adult PMR. Since joining UM, he has been key in the development of multi-disciplinary care clinics for children and adults with neuromuscular diseases. Dr. Hornyak is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Hereditary Sensory Neuropathy Type 1 (HSN1), Cerebral Palsy, and Spasticity. Dr. Hornyak is board certified in Physical Medicine & Rehab.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Dr. Schmidt attended medical school at Michigan State University, and completed her residency training in PM&R at the University of Pittsburgh Medical Center where she also served as chief resident. Dr. Schmidt's clinical responsibilities include outpatient practice focusing on transition into adulthood for pediatric patients with disabilities, cerebral palsy, amyotrophic lateral sclerosis and other neuromuscular conditions. Dr. Schmidt is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Dysferlinopathy, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Dr. Rodriguez is Medical Director of the Wheelchair Seating Clinic and PM&R Administrator in the Michigan Bowel Control Clinic and the Wound Care Clinic. She has been actively involved in research with the Spinal Cord Injury Model System. She has written and collaborated on several research publications and written chapters on SCI sequelae in premier journals and textbooks in PM&R. Dr. Rodriguez has been recognized for her teaching of trainees with the Silver Crutch award. She is the associate SCI fellowship program director. She also serves on the International Standards and Autonomic Standards Committees, two crucial committees of the American Spinal Injury Association that are responsible for development of any new standards documents related to SCI, continuous review and improvement of the existing ASIA documents on neurological and autonomic standards and development and oversight of the International Data Sets project. Dr. Rodriguez is rated as an Advanced provider by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Autonomic Dysreflexia.

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Experienced provider by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.